Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) just unveiled an update.
Charmacy Pharmaceutical Co., Ltd. has announced that its board of directors will hold a meeting on March 28, 2025, to consider and approve the company’s annual results for the year ended December 31, 2024. The meeting will also discuss the recommendation for the payment of a final dividend, if applicable. This announcement signifies a critical step in the company’s financial reporting and potential dividend distribution, which could impact investor sentiment and the company’s market positioning.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products.
YTD Price Performance: -20.61%
Average Trading Volume: 4,805
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$840.2M
See more insights into 2289 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue